Larimar Therapeutics, Inc.

Filed a patent for "molecules for organelle-specific protein delivery" on Thu, August 1, 2024

Filed a patent for "molecules for organelle-specific protein delivery" on Thu, July 11, 2024

Filed a patent for "frataxin-sensitive markers for monitoring frataxin-replacement therapy" on Sun, July 31, 2022

Filed a patent for "frataxin-sensitive markers for monitoring frataxin-replacement therapy" on Thu, November 9, 2023

Filed a patent for "frataxin-sensitive lipid markers for monitoring frataxin replacement therapy" on Thu, May 2, 2024